| Dr. Steve J.P. Hsu | |
| Chairman and CEO | |
| ● | Over 35 years in Pharma Industry |
| ● | Founder of Savior Lifetec Corporation |
| ● | VP of RD, ScinoPharm Taiwan |
| ● | Head of Pharma Division, Sinon Corporation |
| ● | Sr. Engineer of Merck & Co., Inc. |
| ● | Ph.D. ChE, Massachusetts Institute of Technology, USA |
| Kai-Der Ko | |
| CSO and Vice President | |
| ● | Over 30 years in Hi-Tech & Biotech Industry |
| ● | CEO, Champion Venture Capital Co., Ltd. |
| ● | Director of long-term investment, China Life Insurance Co., Ltd. |
| ● | AVP, Koos Group Venture capital Co. Ltd. |
| ● | Manager, China Investment & Development Co., Ltd. |
| ● | Researcher, Taiwan Biotech Co., Ltd. |
| ● | Executive Master of Business Administration, National Chengchi University |
| ● | Master of Science in Pharmacy, College of Medicine, National Taiwan University |
| Wen-Hsien Chen | |
| Vice President, Quality Center | |
| ● | Over 28 years in Pharmaceutical Industry |
| ● | Quality Director/Manager of QA at Savior Lifetec Co. Focus on QMS of a Sterile API and Injection Plant |
| ● | Rich experience in MAA and MAH inspections, such as US (FDA), Taiwan (TFDA), EU UK (MHRA), French (Afssaps), Spain (AEMPSM), Japan (PMDA), Korea (KFDA), Brazil (ANVISA), etc. |
| ● | QA Senior Specialist, ScinoPharm Taiwan, Ltd., focus on QMS and product development project, manufacturing scale-up, troubleshooting, etc. |
| ● | Master degree of Chemical Engineering from the Cleveland State University in Ohio, USA |
| ● | Bachelor of Science in Chemical Engineering from the National Taiwan University/ NTU in Taiwan. |
| Dr. Steve, Chih-Chiang Yang | |
| Chief Operating Officer, Tainan Site | |
| ● | Pharmaceutical and biotechnical product development experience over 23 years |
| ● | Develop drug product to launch on market over 20 items |
| ● | Professional skill in preparation of solid dosage form and injection delivery system, controlled release delivery system, pharmaceutical nanotechnology and lyophilization |
| ● | Well-experience in development of difficult generic product and special dosage form, 505(b)2 new formulation, and FIH formulation for NCE |
| ● | Worked as Director of pharmaceutical development department in Pharmaceutical and Medical Technology and Development Center, MOEATeach “Pharmaceutical Technology” course in School of Pharmacy, National Taiwan University |
| ● | Teach “Pharmaceutical Technology” course in School of Pharmacy, National Taiwan University |
| ● | PhD from Center for Drug Delivery Research, The School of Pharmacy, University of London, UK |
| ● | MSc from Graduated Institute of Pharmaceutical Science, National Taiwan University, Taiwan (Major in Pharmaceutics) |
| ● | Bachelor from School of Pharmacy, National Taiwan University, Taiwan |
| Gary Wong | |
| Senior Director, Quality Center | |
| ● | Over 29 years in Pharma/Biotech Industry |
| ● | Focus on science-based Risk Management System (RMS) and Quality Management System (QMS) based on Pharmaceutical Life Cycle Management (LCM) |
| ● | Rich experience in MAA and MAH inspections, such as Taiwan FDA, US FDA, EU QP (Germany, UK...etc.), KFDA, PMDA, France IPSEN, US Thermo Fisher, Canada Baxter,SQA,UniLab,etc. |
| ● | Quality Management Director, Centapharm Healthcare Group |
| ● | QA/RA Manager, Maxigen Biotech Inc. |
| ● | QA/VA Manager, Union Chem&Pharm Inc. |
| ● | Master and Bachelor degree of Chemical Engineering from the National Taiwan Institute of Technology/ NTIT (National Taiwan University of Science and Technology), Taiwan |
| Dr. On Lee | |
| Chief R&D Officer, RD Centert | |
| ● | Over 25 years in pharmaceuticals, fine chemicals, chemical processes |
| ● | PM of over 10 new chemical entities/30 processes development |
| ● | Well-experience in new drug R&D, organic synthesis, fine chemicals, analytical chemistry |
| ● | CRDO and Vice President, TaiwanJ Pharmaceuticals |
| ● | Principle Researcher, Industrial Technology Research Institute |
| ● | Ph.D. Medicinal Chemistry, Graduate School of Pharmacy, National Taiwan University |
| ● | Bachelor, Department of Pharmacy, National Taiwan University |
| Anderson Fan | |
| Senior Director, Sales Department | |
| ● | Master of Pharmacy, National Taiwan University |
| ● | Bachelor of China Medical University |
| ● | Business Development of injection Department, Formosa Laboratories, Inc. |
| ● | BD Manager of Oncology Department, TTY Biopharm Company Limited |
| ● | DMPK Researcher at TaiGen Biotechnology |
| Johnny Lo | |
| Senior Director, Bio Plant Department | |
| ● | Has more than 23 years of rich experiences in leading biopharmaceuticals development and GMP manufacturing |
| ● | Good at implementation of Quality-by-design concept into bioprocess development, improvement, intensification and scale-up, then GMP process validation and commercialized manufacturing. |
| ● | United BioPharma Quality Management Center VP |
| ● | United BioPharma Manufacturing Director |
| ● | UBIA Process Development and GMP manufacturing manager |
| ● | National Chung Cheng University Chemical Engineering Master |
| ● | Tunghai University Chemical Engineering Bechelor |
| Ray Wu | |
| Director, Head of Finance & Accounting (F&A) Department | |
| ● | Over 27 years in Auditing/ Finance & Accounting/ Investment Management/ Business Management |
| ● | Finance Deputy Director, Jabil Green Point Co., Ltd. |
| ● | VP, Shanghai Allwin New Material Co., Ltd. |
| ● | F&A Manager, Kinko Optical Co., Ltd. |
| ● | F&A Manager, Taiwan Union Technology Corporation. |
| ● | F&A Manager and Spokesman, Chung Hwa Chemical Industrial Works, Ltd. |
| ● | Master of Business Administration, National Central University |
| ● | Bachelor of Finance, National Chengchi University |
| Dr. James Ho | |
| Director, Quality Control Centert | |
| ● | Experienced in Biomed field, familiar with Biologics, health food, toxicology of medical device, in vitro diagnostic (IVD). Biologics experience in protein drug, antibody drug, biosimilar, vaccine, cell therapy product CMC development and GMP operation. Technical skill especially in analytical method development, method validation, method transfer, analytical/quality control laboratory management. |
| ● | Head of AD/QC Mycenax Biotech, TW |
| ● | VP of AD/QC Intellective Bio, China |
| ● | Co-founder / CTO Cefety Biotech Lab, China |
| ● | Director of AD CMAB Biomed, China |
| ● | Ph.D. Biotechnology from National Chung-Hsin University |
| ● | B.S. Medical Technology from National Yang-Ming University |
| Dr. Toby Fan | |
| Director, Head of Project Operations Department | |
| ● | Over 17 years of relevant experience in the biotechnology/pharmaceutical industry |
| ● | Focus on CDMO/CMO business currently |
| ● | Previous experience includes the development of the analytical methods, Controlled-/Targeted- drug & gene delivery systems, and lyophilized processes |
| ● | Manager, Project management department. Genovior Biotech Corporation |
| ● | Associate scientist, Formulation R&D Center, TTY Biopharm |
| ● | Postdoctoral Researcher, College of Life Science, National Taiwan University |
| ● | Ph.D., Chemistry from National Tsing Hua University |
| ● | M.S., Applied Chemistry from National Chi Nan University |
| Dr. Yu-Sheng Liu | |
| Director and Executive pharmacist, Head of Formulation Department | |
| ● | Over 14 years of relevant experience in the biotechnology/pharmaceutical industry |
| ● | Focus on the development of pre-formulation, formulation, lyophilized process for scale up, controlled-/targeted- drug delivery systems for pharmaceutical products |
| ● | Manager, Formulation department (R&D in Formulation), Genovior Biotech Corporation |
| ● | Executive pharmacist, Genovior Biotech Corporation |
| ● | Team leader, Formulation Research Lab of Pharmaceutical R&D Center, China Chemical& Pharmaceutical CO., LTD. |
| ● | Resident pharmacist, China Chemical& Pharmaceutical CO., LTD. |
| ● | Instructor, Environment and Life Sciences, Fooyin University |
| ● | Ph.D., Pharmacy from Kaohsiung Medical University |